These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16473137)

  • 1. Sleeping sickness: PEX and drugs.
    Schliebs W
    Biochim Biophys Acta; 2006 Jan; 1763(1):4-5. PubMed ID: 16473137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of Trypanosoma brucei peroxin 16.
    Kalel VC; Schliebs W; Erdmann R
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2326-37. PubMed ID: 26025675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Protein-Protein Interactions: New Options for Developing Drugs against Neglected Tropical Diseases.
    Berg T
    Angew Chem Int Ed Engl; 2017 Sep; 56(40):12048-12050. PubMed ID: 28766862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?
    Bossard G; Cuny G; Geiger A
    Biofactors; 2013; 39(4):407-14. PubMed ID: 23553721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
    Hannaert V
    Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents.
    Laxman S; Beavo JA
    Mol Interv; 2007 Aug; 7(4):203-15. PubMed ID: 17827441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priorities for the elimination of sleeping sickness.
    Welburn SC; Maudlin I
    Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic antimicrobial peptide killing of African trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness.
    Haines LR; Hancock RE; Pearson TW
    Vector Borne Zoonotic Dis; 2003; 3(4):175-86. PubMed ID: 14733670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase and S-adenosylmethionine decarboxylase in trypanosomatids.
    Persson L
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):314-7. PubMed ID: 17371268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Procyclic Agglutination Trypanosomiasis Test (PATT) for the immunodiagnosis of Trypanosoma brucei rhodesiense sleeping sickness in Kenya.
    Ngaira JM; Olaho-Mukani W; Omuse JK; Tengekyon KM; Mbwabi D; Olado D; Njenga JN
    Trop Med Parasitol; 1992 Mar; 43(1):29-32. PubMed ID: 1598505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma brucei infection in a HIV positive Ugandan male.
    Dill EA; Renault C; Kirkpatrick BD
    Clin Lab Sci; 2011; 24(2):85-8. PubMed ID: 21657140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction.
    Kyambadde JW; Enyaru JC; Matovu E; Odiit M; Carasco JF
    Bull World Health Organ; 2000; 78(1):119-24. PubMed ID: 10686746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.
    Cáceres AJ; Michels PA; Hannaert V
    Mol Biochem Parasitol; 2010 Jan; 169(1):50-4. PubMed ID: 19748525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in sleeping sickness therapy.
    Van Nieuwenhove S
    Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [East African sleeping sickness (Trypanosoma rhodesiense infection) in 2 Swiss travelers to the tropics].
    Braendli B; Dankwa E; Junghanss T
    Schweiz Med Wochenschr; 1990 Sep; 120(37):1348-52. PubMed ID: 2218457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.